Meghan FitzGerald is a global healthcare strategist, investor, academic and author. She has worked in every domain of healthcare from front line patient care through the Fortune 500 while serving as an Adjunct Professor at Columbia University. Currently Meg is a private equity investor where she serves as an advisor to several firms including Goldman Sachs and Wellspring Capital. Recently she was the CEO and managing partner at Letter One's inaugural health vehicle allocating ~$4B in three years within pharma services and animal health. Prior to this Meg spent nearly twenty years in Corporate America as an operator and strategist working for many prominent healthcare firms including Merck, Pfizer and Medco. Before transitioning out of corporate America, she was the EVP of Strategy, M&A and Health Policy at Cardinal Health (CAH) and a member of the executive committee. She is a member of the board of directors at Tenet Healthcare (THC) a leading Fortune 200 healthcare services company, founder of K2HealthVentures a life science investment fund and advisor and volunteer at TrekMedics, an international tech non-profit bringing "911 where there is none". Meg obtained a Doctor of Public Health (DrPH) at New York Medical College, focusing on health policy and the social determinants of health. She earned a Master of Public Health from Columbia University and a Bachelor of Nursing from Fairfield University.
Partner L1 Health
Breaking Through the Glass Ceiling Without Injury: Health Status in Executive Women Ascending the Corporate Ladder